本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Tscan Therapeutics, Inc.

1.10
-0.1100-9.09%
盘后1.120.0200+1.82%19:23 EDT
成交量:60.20万
成交额:68.55万
市值:6,224.97万
市盈率:-0.49
高:1.26
开:1.21
低:1.09
收:1.21
数据加载中...
2024/04/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/17

重要事件披露

Form 8-K - Current report
2024/04/17

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/10

SEC问询函

Form CORRESP - Correspondence
2024/04/10

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/04/08

重要事件披露

Form 8-K - Current report
2024/03/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/06

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/06

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/29

重要事件披露

Form 8-K - Current report
2023/12/11

重要事件披露

Form 8-K - Current report
2023/12/07

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report